Clinical trial

The DART DELIVER-02 Study

NCT07217379

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2025-10-02

PhasePHASE1

Study timeline

Study start (actual)2025-10-02Date precision: day

Registry last updated2026-09-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV (Human Immunodeficiency Virus)unresolved

Interventions

VorinostatDRUG · verified · RxNorm: vorinostat

Temporary treatment interruptionOTHER

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

Henry M. Jackson Foundation for the Advancement of Military Medicinecollaborator

US Military HIV Research Programcollaborator

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07217379 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.